Literature DB >> 2834971

Maximum heart rate responses to exercise and isoproterenol in the trained rat.

C P Bolter1, K J Atkinson.   

Abstract

Male rats were assigned to light (C) or strenuous (T) running programs. Both groups ran at 30 m/min, 8% elevation. Over 16 wk, T and C completed 2,939 +/- 72 and 507 +/- 7 min (mean +/- SE). In a graded running test, maximum exercise heart rates for T and C were 542 +/- 7 and 554 +/- 6 beats/min (P greater than 0.05). Heart rates elicited by maximum effective concentrations of isoproterenol (ISO) in vivo and in vitro were 483 +/- 8 and 489 +/- 11 beats/min for T and 499 +/- 5 and 502 +/- 5 beats/min for C (no difference between groups or treatments). A lower heart rate was recorded in T for both resting (353 +/- 7 vs. 373 +/- 4 beats/min) and in vitro intrinsic states (231 +/- 22 vs. 299 +/- 22 beats/min) (P less than 0.05 for both conditions). The difference between maximum ISO-stimulated and maximum exercise heart rates was attributed to a temperature difference. In a separate group of lightly trained rats, ISO was administered intravenously during hard exercise when heart rate approached exercise maximum. Heart rate after ISO did not increase beyond the maximum heart rate observed in a control run. It was concluded that the maximum chronotropic response to sympathetic stimulation can be elicited during hard exercise and that maximum exercise heart rate reflects this limit rather than a saturation of cardiac sympathetic activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834971     DOI: 10.1152/ajpregu.1988.254.5.R834

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Identifying physiological origins of baroreflex dysfunction in salt-sensitive hypertension in the Dahl SS rat.

Authors:  Scott M Bugenhagen; Allen W Cowley; Daniel A Beard
Journal:  Physiol Genomics       Date:  2010-03-30       Impact factor: 3.107

2.  Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation.

Authors:  Christopher P Jackman; Asvin M Ganapathi; Huda Asfour; Ying Qian; Brian W Allen; Yanzhen Li; Nenad Bursac
Journal:  Biomaterials       Date:  2018-01-03       Impact factor: 12.479

3.  Dynamic culture yields engineered myocardium with near-adult functional output.

Authors:  Christopher P Jackman; Aaron L Carlson; Nenad Bursac
Journal:  Biomaterials       Date:  2016-09-30       Impact factor: 12.479

Review 4.  Small and large animal models in cardiac contraction research: advantages and disadvantages.

Authors:  Nima Milani-Nejad; Paul M L Janssen
Journal:  Pharmacol Ther       Date:  2013-10-15       Impact factor: 12.310

5.  The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension.

Authors:  Timothy D Bryson; Teja S Pandrangi; Safa Z Khan; Jiang Xu; Tengis S Pavlov; Pablo A Ortiz; Edward Peterson; Pamela Harding
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-06       Impact factor: 4.733

6.  The role of stretch, tachycardia and sodium-calcium exchanger in induction of early cardiac remodelling.

Authors:  Natasa Djalinac; Senka Ljubojevic-Holzer; Ingrid Matzer; Ewald Kolesnik; Katharina Jandl; Birgit Lohberger; Peter Rainer; Akos Heinemann; Simon Sedej; Dirk von Lewinski; Egbert Bisping
Journal:  J Cell Mol Med       Date:  2020-06-22       Impact factor: 5.310

7.  Is rate-pressure product of any use in the isolated rat heart? Assessing cardiac 'effort' and oxygen consumption in the Langendorff-perfused heart.

Authors:  Dunja Aksentijević; Hannah R Lewis; Michael J Shattock
Journal:  Exp Physiol       Date:  2015-12-16       Impact factor: 2.969

Review 8.  Slowing down as we age: aging of the cardiac pacemaker's neural control.

Authors:  Sabrina Choi; Matthias Baudot; Oscar Vivas; Claudia M Moreno
Journal:  Geroscience       Date:  2021-07-22       Impact factor: 7.713

9.  Metoprolol Impairs β1-Adrenergic Receptor-Mediated Vasodilation in Rat Cerebral Arteries: Implications for β-Blocker Therapy.

Authors:  Christopher L Moore; David S Henry; Samantha J McClenahan; Kelly K Ball; Nancy J Rusch; Sung W Rhee
Journal:  J Pharmacol Exp Ther       Date:  2020-10-25       Impact factor: 4.030

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.